---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002294"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:32:20.231995+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals posts updated investor presentation with no material new information

## Summary
- Filed updated investor presentation as of April 7, 2025, under Item 8.01.
- Presentation contains only standard disclaimers and forward-looking statements; no new financial or operational data disclosed.
- No changes to guidance, product pipeline, revenue, or other key metrics were reported.

## SEC filing metadata
- accession: 0001683168-25-002294
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825002294/0001683168-25-002294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825002294/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002294
- JSON: https://secwatch.observer/filing/0001683168-25-002294.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.